Introduction
Ten-year review of otitis media pathogens
Comparative United States and European trials of loracarbef in the treatment of acute otitis media
Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis
Loracarbef vs. cefaclor in pediatric skin and skin structure infections
Infectious diseases and child day care
The Carbacephems
In Vitro Activity of Loracarbef and Effects of Susceptibility Test Methods
Pharmacokinetic Profile of Loracarbef
The Safety Profile of Loracarbef
Contributors